Alpha 2.0
Login Register
» Authors » N Jay

N Jay

Explore the profile of N Jay including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 886
Followers 0
Related Specialties
Infectious Diseases
Microbiology
Oncology
Top 10 Co-Authors
J M Palefsky
T M Darragh
E A Holly
M L Ralston
J M Berry
J Palefsky
C J Hogeboom
A B Moscicki
K Powell
E Hanson
Published In
J Acquir Immune Defic Syndr Hum Retrovirol
Rev Epidemiol Sante Publique
J Low Genit Tract Dis
J Eur Acad Dermatol Venereol
J Clin Endocrinol Metab
Affiliations
Soon will be listed here.
Recent Articles
1.
Do we really need guidelines for high resolution anoscopy during the COVID-19 pandemic? - Response
Hillman R, Cuming T, Jay N, Goldstone S, Berry-Lawhorn M, Barroso L, et al.
Colorectal Dis . 2020 Jun; 22(9):1024-1025. PMID: 32564503
No abstract available.
2.
Quantin C, Chatellier G, Mayeux D, Jay N
Rev Epidemiol Sante Publique . 2019 Feb; 67 Suppl 2:S69. PMID: 30709631
No abstract available.
3.
A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men
Ellsworth G, Lensing S, Ogilvie C, Lee J, Goldstone S, Berry-Lawhorn J, et al.
Papillomavirus Res . 2018 May; 6:11-14. PMID: 29807211
No abstract available.
4.
Focal hyperkeratosis overlying the palmar faces of interphalangeal and metacarpophalangeal joints revealing a juvenile dermatomyositis
Abasq-Thomas C, Devauchelle V, Fraitag S, Jay N, Gourier G, Le Duc Pennec A, et al.
J Eur Acad Dermatol Venereol . 2017 Sep; 32(3):e97-e98. PMID: 28895209
No abstract available.
5.
Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study
Peters N, Jay N, Cridlig J, Rostoker G, Frimat L
BMC Nephrol . 2017 Mar; 18(1):97. PMID: 28320343
Background: Intravenous iron is widely used to control anemia in dialysis patients and limits costs related to erythropoiesis-stimulating agents (ESA). Current guidelines do not clearly set upper limits for serum...
6.
Quantin C, Chatellier G, Le Goaster C, Mayeux D, Jay N
Rev Epidemiol Sante Publique . 2017 Feb; 65 Suppl 1:S3. PMID: 28222920
No abstract available.
7.
Papillary lesions of the anal canal
Darragh T, Jay N, Berry M, Costa M, Ralston M, Holly E, et al.
J Low Genit Tract Dis . 2015 May; 3(1):36. PMID: 25950303
No abstract available.
8.
The economic costs of severe anaphylaxis in France: an inquiry carried out by the Allergy Vigilance Network
Flabbee J, Petit N, Jay N, Guenard L, Codreanu F, Mazeyrat R, et al.
Allergy . 2008 Feb; 63(3):360-5. PMID: 18269678
Background: The prevalence of severe anaphylaxis, between 1 and 3 per 10,000, has increased sharply over recent years, with a rate of lethality of 1%. The economic burden is unknown....
9.
Clinical and biological assessments of the undervirilized male
Nicolino M, Bendelac N, Jay N, Forest M, David M
BJU Int . 2004 Apr; 93 Suppl 3:20-5. PMID: 15086438
No abstract available.
10.
Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection
Palefsky J, Holly E, Ralston M, Da Costa M, Bonner H, Jay N, et al.
J Acquir Immune Defic Syndr . 2001 Dec; 28(5):422-8. PMID: 11744829
The effect of highly active antiretroviral therapy (HAART) on the natural history of anal squamous intraepithelial lesions (ASIL)-the likely anal cancer precursor-and anal human papillomavirus (HPV) infection is unknown. ASIL...